Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia
Blood 2023 Jul 13;[EPub Ahead of Print], J Senapati, S Urrutia, S Loghavi, NJ Short, GC Issa, A Maiti, HA Abbas, NG Daver, N Pemmaraju, SA Pierce, KS Chien, K Sasaki, TM Kadia, D Hammond, G Borthakur, KP Patel, F Ravandi, HM Kantarjian, G Garcia-Manero, CD DiNardoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.